Two of the Chinese clinical trials affected by the lack of subjects involve the antiviral medication remdesivir. Photo: AP Two of the Chinese clinical trials affected by the lack of subjects involve the antiviral medication remdesivir. Photo: AP
Two of the Chinese clinical trials affected by the lack of subjects involve the antiviral medication remdesivir. Photo: AP

China cancels coronavirus clinical trials due to shortage of patients

  • Many studies halted ‘because no one expected that China would control the epidemic so quickly’, respiratory disease expert Zhong Nanshan says
  • Almost 600 clinical trials have been registered since the outbreak began, which is evidence of Chinese researchers’ determination to find a treatment for Covid-19, he says

Topic |   Coronavirus pandemic
Two of the Chinese clinical trials affected by the lack of subjects involve the antiviral medication remdesivir. Photo: AP Two of the Chinese clinical trials affected by the lack of subjects involve the antiviral medication remdesivir. Photo: AP
Two of the Chinese clinical trials affected by the lack of subjects involve the antiviral medication remdesivir. Photo: AP
READ FULL ARTICLE